RNA-Based Therapies Back In Spotlight As Chinese Biotechs Raise $366m

 
• By Dexter Jie Yan
  
fund raising
Investors reignited interest in Chinese biotechs focused on nucleic acid therapeutics • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia